Goldman Sachs Upgrades Impax Laboratories (IPXL) to Neutral
Tweet
Share
E-mailGet Alerts IPXL Hot Sheet
Price: $18.30 --0%
Rating Summary:
8 Buy, 15 Hold, 3 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 4 | Down: 8 | New: 54
Rating Summary:
8 Buy, 15 Hold, 3 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 4 | Down: 8 | New: 54
Join SI Premium – FREE
Goldman Sachs upgraded Impax Laboratories (NASDAQ: IPXL) from Sell to Neutral.
For an analyst ratings summary and ratings history on Impax Laboratories click here. For more ratings news on Impax Laboratories click here.
Shares of Impax Laboratories closed at $25.40 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Morgan Stanley Upgrades Telecom Argentina (TEO) to Overweight
- JPMorgan Upgrades Japan Post Insurance Co., Ltd (7181:JP) (JPPIF) to Overweight
- Axis Capital Limited Upgrades Tata Elxsi Ltd (TELX:IN) to Buy (1)
Create E-mail Alert Related Categories
UpgradesRelated Entities
Goldman SachsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
